Radiation Oncology/Therapy: Page 20

Shine secures Dutch approval for terbium isotope development grant

By AuntMinnie.com staff writers

Shine Technologies has secured approval from the Dutch government for a grant proposal to develop terbium isotopes for nuclear medicine imaging.

October 17, 2022

FDA completes SpectronRx facility inspection

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has completed an inspection of contract development and manufacturing organization SpectronRx's South Bend, Indiana, manufacturing facility.

October 16, 2022

FAPI-PET predicts outcomes in patients with esophageal cancer

By Will Morton

PET imaging with a fibroblast activation protein inhibitor (FAPI) radiotracer may predict whether patients with esophageal cancer will respond to chemoradiotherapy, according to a study published October 13 in the Journal of Nuclear Medicine.

October 16, 2022

First patient imaged in Sofie's FAPI-PET trial

By AuntMinnie.com staff writers

Sofie Biosciences has performed imaging on the first patient in a phase II clinical trial to test the use of its gallium-68 fibroblast activation protein inhibitor (FAPI) PET radiotracer in patients with pancreatic cancer.

October 14, 2022

ART to offer AccuBoost technology to China

By AuntMinnie.com staff writers

Radiation therapy firm Advanced Radiation Therapy (ART) entered into a technology transfer deal with Best Medical Technology to offer its AccuBoost image-guided partial-breast irradiation system in China.

October 14, 2022

Telix obtains Health Canada clearance for Illuccix

By AuntMinnie.com staff writers

Telix Americas has received clearance from Health Canada for its prostate-specific membrane antigen-PET imaging agent, Illuccix.

October 13, 2022

ITM to boost Lu-177 production

By AuntMinnie.com staff writers

ITM Isotope Technologies Munich completed work on a new production line for non-carrier-added lutetium-177 (Lu-177) at its manufacturing facility in Garching, Germany.

October 12, 2022

Accuray to unveil new Radixact capabilities at ASTRO

By AuntMinnie.com staff writers

Accuray will highlight new breast cancer treatment capabilities for its Radixact image-guided radiation therapy system at the American Society for Radiation Oncology (ASTRO) 2022 annual meeting being held October 23-26 in San Antonio, TX.

October 12, 2022

RBS acquires Apollo Healthcare

By AuntMinnie.com staff writers

Radiation Business Solutions (RBS) has acquired Apollo Healthcare, with the former saying the acquisition will allow the Apollo team to remain focused on making proton therapy more available to cancer patients.

October 11, 2022

Nucleus RadioPharma forms to provide radiopharmaceuticals

By AuntMinnie.com staff writers

Venture capital firm Eclipse and the Mayo Clinic are creating and providing seed funding for a new company called Nucleus RadioPharma that aims to provide cancer patients access to therapeutic radiopharmaceuticals.

October 11, 2022

NorthStar signs deal with Eckert & Ziegler for hot cells

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has signed an agreement with Eckert & Ziegler Isotope Technologies Dresden for hot cells and related equipment to be used in NorthStar's construction of a production facility for noncarrier-added actinium-225 (Ac-225).

October 10, 2022

Telix highlights EANM presentations

By AuntMinnie.com staff writers

Telix Pharmaceuticals is highlighting presentations on the company's theranostics radiopharmaceuticals that will take place at the European Association of Nuclear Medicine (EANM) 2022 Congress, in Barcelona, Spain, October 15-19.

October 10, 2022

Previous Page

Page 20 of 463

Next Page